Guidance on acute ischemic stroke, chronic migraine, cognitive disorders, ADHD, depression, and central nervous system health.
Clinical evaluation of Attention-Deficit/Hyperactivity Disorder in adults: DSM-5-TR diagnostic criteria, neurobiology of dopamine/norepinephrine, stimulants vs non-stimulants.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Neurological clinical guide to chronic migraine: trigeminovascular activation, Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, gepants, and the PREEMPT Botox protocol.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Emergency neurological protocol for acute ischemic stroke: BE-FAST screening, NIHSS scoring, IV tenecteplase vs alteplase, and mechanical thrombectomy within 24 hours.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Evidence-based clinical guidelines on Major Depressive Disorder (MDD): STAR*D sequencing, first-line SSRIs/SNRIs, repetitive Transcranial Magnetic Stimulation (rTMS), and esketamine nasal spray.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Diagnostic differentiation between normal aging, Mild Cognitive Impairment (MCI), and early Alzheimer's disease: MoCA testing, CSF p-tau217 biomarkers, and anti-amyloid therapies.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Clinical management of Generalized Anxiety Disorder (GAD): GAD-7 screening thresholds, hyperactive amygdalar fear circuitry, first-line SSRIs/SNRIs, and cognitive restructuring.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Neurological guide to Parkinson's disease: substantia nigra neurodegeneration, classic motor tetrad, Carbidopa/Levodopa motor fluctuations, and Deep Brain Stimulation (DBS) neuromodulation.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Clinical evaluation of Obstructive Sleep Apnea (OSA): polysomnography diagnostic metrics, nocturnal hypoxemic surges, resistant hypertension, and positive airway pressure (CPAP).
Medically Reviewed by Dr. Arthur Vance, MD, FACP
Sports and trauma neurology review of mild Traumatic Brain Injury (concussion): the Giza-Hovda neurometabolic cascade, SCAT6 sidelines assessment, and the 6-step return-to-activity protocol.
Medically Reviewed by Dr. Arthur Vance, MD, FACP
